A study of ISIS 420915 in patients with Amyloid Polyneuropathy

• Research type

  Research Study

• Full title

  A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients with Familial Amyloid Polyneuropathy

• IRAS ID

  116569

• Contact name

  Carol Whelan

• Contact email

  c.whelan@ucl.ac.uk

• Sponsor organisation

  Isis Pharmaceuticals, Inc.

• Eudract number

  2012-001831-30

• ISRCTN Number

  n/a

• REC name

  London - Harrow Research Ethics Committee

• REC reference

  13/LO/0100

• Date of REC Opinion

  22 Apr 2013

• REC opinion

  Further Information Favourable Opinion